title: Experience of the National Cancer Institute Community Cancer Centers Program on Community-Based Cancer Clinical Trials Activity.
abstract: OBJECTIVE
  A goal of the National Cancer Institute Community Cancer Centers Program (NCCCP) was to improve cancer research capacity in community settings. We examined research capacity development during the pilot phase of the NCCCP within the context of national trends in clinical trial activity with respect to the number and phase of trials, total accrual, and accrual of underserved populations.
  
  
  METHODS
  We examined self-reported data from NCCCP sites during 2007 to 2010, supplemented with data from the National Cancer Institute Cancer Therapy Evaluation Program.
  
  
  RESULTS
  Trial availability and accrual improved more quickly at NCCCP sites compared with national trends. Phase III trial availability increased 8% nationally versus 16% across NCCCP sites, and accrual increased 30% nationally versus 133% across NCCCP sites. Accrual of racial and ethnic minorities rose 82%, from 83 to 151 patients, and accrual of patients age ≥ 65 years rose by 221%, from 200 to 641 patients. Change in trial portfolio and accrual differed by sophistication of the site and by prior experience in conducting clinical trials at the site.
  
  
  CONCLUSIONS
  Despite the short duration, the NCCCP pilot resulted in an increase in the number of open trials as well as patient accrual at a faster rate than that observed nationally. These results, coupled with insights into the relative success of sites with varying sophistication at the outset, provide promise that lessons learned can be applied more broadly to increase research participation.
authors.affiliation: Duke Clinical Research Institute; and Duke Cancer Institute, Durham, NC bhirsch@flatiron.com.
authors.forename: Bradford R
authors.initials: BR
authors.lastname: Hirsch
authors.affiliation: Duke Clinical Research Institute; and Duke Cancer Institute, Durham, NC.
authors.forename: Susan C
authors.initials: SC
authors.lastname: Locke
authors.affiliation: Duke Clinical Research Institute; and Duke Cancer Institute, Durham, NC.
authors.forename: Amy P
authors.initials: AP
authors.lastname: Abernethy
mesh_terms: D002173:Cancer Care Facilities; D002986:Clinical Trials as Topic; D003153:Community Health Services; D016208:Databases, Factual; D006801:Humans; D008495:Medical Oncology; D054547:National Cancer Institute (U.S.); D012106:Research; D014481:United States